Incyte | INCY - EPS Earnings Per Share

Stock Price
100.09
Daily Change
0.11 0.11%
Monthly
-3.27%
Yearly
36.77%
Q1 Forecast
98.18

Incyte reported $1.8 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 1.80 1.93 1.43 Feb/10 2026
FY2025Q3 Sep/2025 2.26 1.58 1.07 Oct/28 2025
FY2025Q2 Jun/2025 1.57 1.40 -1.82 Jul/29 2025
FY2025Q1 Mar/2025 1.16 1.01 0.64 Apr/29 2025
FY2024Q4 Dec/2024 1.43 1.51 1.06 Feb/10 2025




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Agenus USD -1.03 1.01 Mar/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
BioCryst Pharmaceuticals USD -0.13 0.06 Dec/2024
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Exelixis USD 0.97 0.19 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
MacroGenics USD 0.27 0.84 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Novartis USD 2.02 0.04 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025